Loading…
Loading…
HOUSTON, Oct. 19, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the third fiscal quarter ended Sept. 30, 2026, on Thursday, Nov. 5, 2026, after the market close.
Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.
Nutex Health and Elevance Health may be underpriced, despite their share growth this year.
Nutex Health Inc. (NASDAQ: NUTX - Get Free Report)'s share price reached a new 52-week high on Monday. The stock traded as high as $225.25 and last traded at $225.14, with a volume of 126373 shares traded. The stock had previously closed at $216.50. Wall Street Analysts Forecast Growth Several equities research analysts have commented on
HCA Healthcare (NYSE: HCA - Get Free Report) and Nutex Health (NASDAQ: NUTX - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations. Analyst Ratings This is a breakdown of current
Five stocks showing recent price strength include VNCE, VRA, AOUT, NUTX and FET, with strong momentum and improving earnings estimates.
Let's take a look at four stocks, NUTX, RCMT, TILE and QUAD, with impressive net profit margins for a robust portfolio.
Nutex Health has surged 134% since April, driven by its out-of-network micro-hospital model and expanding margins. It has staged a turnaround in 2026, driven by strong EPS growth after years of struggle. The company leverages the No Surprises Act's arbitration process to sustain margins against insurer underpayment, making dispute resolution central to its current business.